Home/Filings/4/0000878088-11-000053
4//SEC Filing

RICE THOMAS P 4

Accession 0000878088-11-000053

CIK 0000878088other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:19 PM ET

Size

5.9 KB

Accession

0000878088-11-000053

Insider Transaction Report

Form 4
Period: 2011-05-17
Transactions
  • Award

    Restricted Stock Units

    2011-05-17+36513,523 total
    From: 2012-05-17Common Stock (365 underlying)
Footnotes (1)
  • [F1]Pursuant to the Amended and Restated 1997 Directors' Stock and Deferred Fee Plan, the Reporting Person was granted a Restricted Stock Unit Award of the number of shares of the Issuer's common stock having an aggregate Fair Market Value equal to $12,500 on the date of grant. The Fair Market Value of each Restricted Stock Unit is equal to the closing price of the Issuer's common stock as reported by The New York Stock Exchange, Inc. on the date of grant, which was $34.31. The Restricted Stock Units vest on the one year anniversary of the date of grant. Each stock unit is the economic equivalent of one share of common stock, but the shares of common stock are distributed only upon termination of the Reporting Person's services as a director of the Issuer.

Issuer

PAR PHARMACEUTICAL COMPANIES, INC.

CIK 0000878088

Entity typeother

Related Parties

1
  • filerCIK 0001230728

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:19 PM ET
Size
5.9 KB